AC
TECH icon

Athos Capital’s Bio-Techne TECH Stock Holding History

Athos Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.07M Buy
+100,000
New +$5.4M 2.51% 12

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Athos Capital's TECH Position: Q2 2026 in Review

Athos Capital opened a new position in Bio-Techne (TECH) in Q2 2026: 100,000 shares worth $7.07M. The stake represents 2.51% of the portfolio and ranks #12 among its holdings.

593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Athos Capital held 100,000 shares of Bio-Techne worth $7.07M as of Q2 2026.
  • Bio-Techne was a new Athos Capital position in Q2 2026.
  • Bio-Techne made up 2.51% of Athos Capital's portfolio in Q2 2026, its #12 holding.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Athos Capital's 13F filing for Q2 2026, filed 13 Aug 2026.